Skip to main content
OpenTrials

Clinical trial condition

Non-Muscle Invasive Bladder Neoplasms

Explore clinical trials studying Non-Muscle Invasive Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

209 public trials 72 recruiting studies
Refine in advanced search Browse all conditions

Non-Muscle Invasive Bladder Neoplasms trial results

Recruiting

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

NCT07673016

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +21 more
Locations
  • Urology San Diego Oceanside, California, United States
  • Genesis Research, LLC San Diego, California, United States
  • Urology Associates of Silicon Valley San Jose, California, United States
  • UroPartners, LLC Chicago, Illinois, United States
View all 23 locations
View Trial Details
Recruiting

DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr

NCT04106115

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
Locations
  • Cambridge University NHS FT Cambridge, United Kingdom
  • Guy's and St Thomas' NHS Foundation Trust London, United Kingdom
  • Royal Free London NHS FT London, United Kingdom
  • The Royal Marsden NHS Foundation Trust London, United Kingdom
View Trial Details
Recruiting

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

NCT05710848

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • East Valley Urology Center of Arizona Mesa, Arizona, United States
  • Arizona Urology Specialists Tucson, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • Unio Specialty Care - A Genesis Healthcare Partners Facility Bakersfield, California, United States
View all 20 locations
View Trial Details
Recruiting

AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer

NCT05002556

Conditions
Carcinoma, Disease Attributes, Female Urogenital Diseases, +17 more
Locations
  • Hopital Prive de Provence Aix-en-Provence, France
  • CHU Angers Angers, France
  • Hopital Privé Arras les Bonnettes Arras, France
  • Centre hospitalier Privé Montgradé Aubergenville, France
View all 44 locations
View Trial Details
Recruiting

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

NCT07283835

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +15 more
Locations
  • Peking University First Hospital (First Clinical Medical School of Peking University) Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View all 14 locations
View Trial Details

Related conditions